Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jinyouli for prevention of chemotherapy-induced neutropenia in solid tumors
CTR20140876Phase 4Completed
- Sponsor
- Grand Pharmaceutical Group
- Start
- Dec 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of pegfilgrastim in chemotherapy-induced neutropenia (CIN), sponsored by Grand Pharmaceutical Group. Started Dec 2014; status: completed.
02
Drugs
pegfilgrastim
03
Conditions
chemotherapy-induced neutropenia (CIN)
Beyond the preview
Go deeper on CTR20140876.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140876.